14.81
-1.88
(-11.26%)
At close: January 10 at 4:00:01 PM EST
14.81
0.00
(0.00%)
After hours: January 10 at 4:00:12 PM EST
Breakdown
TTM
12/31/2023
Operating Cash Flow
-60,739.00
-27,181.00
Investing Cash Flow
-280,732.00
-78,860.00
Financing Cash Flow
221,478.00
145,136.00
End Cash Position
39,419.00
70,254.00
Capital Expenditure
-3,616.00
-1,636.00
Issuance of Capital Stock
221,612.00
145,274.00
Repurchase of Capital Stock
--
-4.00
Free Cash Flow
-64,355.00
-28,817.00
12/31/2023 - 6/7/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTV Artiva Biotherapeutics, Inc.
9.35
-8.87%
MBX MBX Biosciences, Inc.
13.69
-5.65%
CTNM Contineum Therapeutics, Inc.
13.29
-0.60%
LXEO Lexeo Therapeutics, Inc.
6.39
-6.30%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
BCAX Bicara Therapeutics Inc.
14.38
-5.70%
MLYS Mineralys Therapeutics, Inc.
9.87
-11.87%
CNTA Centessa Pharmaceuticals plc
15.64
-2.86%
IGMS IGM Biosciences, Inc.
2.0900
-66.29%
SEPN Septerna, Inc.
17.99
-13.72%